The Effect of Semantic Support on Word Learning

NCT ID: NCT05921214

Last Updated: 2025-06-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-10

Study Completion Date

2026-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to compare word learning outcomes in late talking toddlers who are taught different types of words. The main question it aims to answer is if teaching words that come from categories that children already know (e.g., animals) will aid overall word learning. Children will take part in the Vocabulary Acquisition and Usage for Late Talkers (VAULT) word learning treatment and be taught words from more familiar or less familiar categories to see which group learns more words overall.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Children will be assigned to either the familiar or less-familiar word group. All children will receive 8 weeks of Vocabulary Acquisition and Usage for Late Talkers (VAULT) word learning treatment (2x/wk for 30 minutes each session). The investigators will measure how well children learn the words they are taught as well as the words that are in the environment, but not explicitly taught (control words). This will help us know if their learning is due to treatment or maturation. The investigators will compare children to themselves (taught words v. control words) to ensure that the overall treatment is working. Then, the investigators will compare children in the familiar word group to children in the less-familiar word group to see which group learns more overall.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Language Development Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Using treatment effect sizes, children will be compared to themselves (treatment words v. control words) and across groups (familiar word group v. less-familiar word group).
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Caregivers
The late talkers and their caregivers will not explicitly be told what condition their child is in.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Familiar Words

In this condition, children will learn new words that come from semantic categories (e.g., animals, body parts) from which they currently understand at least several words.

Group Type EXPERIMENTAL

VAULT Phase 5

Intervention Type BEHAVIORAL

This is an input-based vocabulary learning treatment based on principles of statistical learning.

Less-Familiar Words

In this condition, children will learn new words that come from semantic categories (e.g., animals, body parts) from which they currently understand few or no words.

Group Type ACTIVE_COMPARATOR

VAULT Phase 5

Intervention Type BEHAVIORAL

This is an input-based vocabulary learning treatment based on principles of statistical learning.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

VAULT Phase 5

This is an input-based vocabulary learning treatment based on principles of statistical learning.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Native English Speaking
* Pass pure tone hearing screening or medical report of normal hearing
* 2-3 Years of age
* MCDI expressive scale \<10th percentile

Exclusion Criteria

* Parental report of other diagnoses
* Enrolled in concurrent treatment elsewhere
* Nonverbal IQ \<75 as measured by the Bayley scales
* Parents unable to consistently bring child to treatment sessions
Minimum Eligible Age

2 Years

Maximum Eligible Age

4 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

Sponsor Role collaborator

University of Arizona

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mary Alt, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Arizona

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Arizona

Tucson, Arizona, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mary Alt, PhD

Role: CONTACT

520-626-6180

Nora Evans-Reitz, MS

Role: CONTACT

520-626-6885

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nora Evans-Reitz, M.S.

Role: primary

520-626-6885

Cecilia Figueroa, M.S.

Role: backup

520-626-6885

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2R01DC015642-06

Identifier Type: NIH

Identifier Source: secondary_id

View Link

Late Talker Phase 5

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Stimulus-Stimulus Pairing Study
NCT02464527 COMPLETED NA